Neurology Drugs
141 drugs
Quick-reference dosing for 141 neurology medicines, aligned to current UK formularies. Each entry lists adult, paediatric and (where relevant) neonatal doses, renal and hepatic adjustments, contraindications, key interactions, monitoring and clinical pearls — with the source reference. Always confirm doses against current prescribing references before prescribing.
- AcetazolamideCarbonic anhydrase inhibitor
- AlemtuzumabMultiple Sclerosis — Disease-Modifying Therapy
- AlemtuzumabAnti-CD52 monoclonal antibody
- AlmotriptanTriptan (5-HT1B/1D agonist)
- Alteplase (tPA)Thrombolytic
- AmantadineDopamine Agonist / NMDA Antagonist (Anti-Parkinsonian)
- Amantadine HydrochlorideDopaminergic / Antiviral (Adamantane Derivative)
- AmifampridinePotassium Channel Blocker (Neuromuscular Junction Facilitator)
- Amitriptyline (Neuropathic Pain / Migraine)Tricyclic Antidepressant / Neuropathic Pain Agent
- ApomorphineDopamine Agonist — Parkinson's Disease Rescue / Continuous Infusion
- Apomorphine HydrochlorideDopamine Receptor Agonist (Non-ergot)
- AspirinAntiplatelet
- Aspirin with MetoclopramideAnalgesic + Antiemetic (Migraine Treatment)
- AtalurenRead-Through Agent (Premature Stop Codon Suppressor)
- AtogepantCGRP Receptor Antagonist (Gepant — Migraine Prevention)
- BaclofenMuscle Relaxant — GABA-B Agonist
- Benzatropine mesilateAnticholinergic (antimuscarinic, antiparkinsonian)
- BetahistineHistamine Analogue — Vertigo / Ménière's Disease
- Botulinum toxin type ANeuromuscular blocker (presynaptic)
- BrivaracetamAntiepileptic — SV2A Ligand (Focal Seizures)
- CannabidiolAntiepileptics
- CannabidiolAntiepileptic (cannabinoid)
- Cannabis extractTHC + CBD oromucosal spray
- CarbamazepineAntiepileptic / Trigeminal neuralgia
- CenobamateAnti-epileptic
- CladribineMultiple Sclerosis — Disease-Modifying Therapy
- ClobazamAntiepileptic — 1,5-Benzodiazepine
- ClonazepamBenzodiazepine
- Clopidogrel (Stroke/TIA Secondary Prevention)Antiplatelet (P2Y12 Inhibitor)
- Co-beneldopaLevodopa + benserazide
- Co-careldopa (carbidopa + levodopa)Antiparkinsonian (dopamine precursor + decarboxylase inhibitor)
- Dabigatran (Stroke Prevention — AF)Direct Oral Anticoagulant — Thrombin Inhibitor
- DaridorexantSleep Disorders
- DexamethasoneCorticosteroid
- Diazepam (Rectal)Benzodiazepine / Antiepileptic
- Dimethyl fumarateFumaric acid ester (immunomodulator)
- Dimethyl FumarateDisease-Modifying Therapy — Relapsing-Remitting Multiple Sclerosis
- DipyridamoleAntiplatelet (phosphodiesterase inhibitor + adenosine reuptake inhibitor)
- Diroximel fumarateFumaric acid ester (prodrug of monomethyl fumarate)
- DonepezilAcetylcholinesterase Inhibitor
- EdaravoneRare Neurological Disorders
- Edoxaban (Stroke Prevention)Stroke Prevention
- Efgartigimod alfaNeonatal Fc receptor (FcRn) blocker
- EletriptanTriptan (5-HT₁B/1D agonist)
- EntacaponeCOMT Inhibitor — Parkinson's Disease
- EplontersenAntisense oligonucleotide (TTR silencer)
- EptinezumabAnti-CGRP monoclonal antibody (IV)
- ErenumabCGRP Receptor Monoclonal Antibody — Migraine Prevention
- Eslicarbazepine acetateAntiepileptic (sodium channel blocker)
- EthosuximideAntiepileptic — T-type Calcium Channel Blocker
- FampridinePotassium channel blocker
- FenfluramineSerotonergic antiseizure agent
- FingolimodMultiple Sclerosis — Disease-Modifying Therapy
- FingolimodSphingosine-1-phosphate receptor modulator
- Foslevodopa with foscarbidopaContinuous SC levodopa/carbidopa
- Fosphenytoin sodiumPhenytoin prodrug (anticonvulsant)
- FremanezumabAnti-CGRP monoclonal antibody
- Frovatriptan5-HT1B/1D agonist (triptan)
- GabapentinAlpha-2-Delta Ligand — Neuropathic Pain / Epilepsy Adjunct
- GalantamineAcetylcholinesterase Inhibitor — Dementia
- GalcanezumabAnti-CGRP monoclonal antibody
- Glatiramer acetateImmunomodulator
- Hypertonic Saline 3%Osmotic agent / ICP reduction
- IdebenoneAntioxidant / synthetic ubiquinone analogue
- Interferon betaInterferon (immunomodulator)
- Interferon Beta-1aDisease-Modifying Therapy — MS (Interferon)
- L-CarnitineAntidote / Metabolic Agent
- LacosamideAntiepileptic — Sodium Channel Slow Inactivation Enhancer
- LamotrigineAnticonvulsant (Sodium Channel Blocker)
- LasmiditanMigraine
- LevetiracetamAntiepileptic
- Levetiracetam IV (Status Epilepticus)Antiepileptic — Second-Line Status Epilepticus
- Levodopa with carbidopa and entacaponeLevodopa + DDC inhibitor + COMT inhibitor
- Levodopa-Carbidopa (Co-Careldopa)Dopamine Precursor / Decarboxylase Inhibitor
- Mannitol 20%Osmotic Diuretic / ICP reduction
- MemantineNMDA Receptor Antagonist — Dementia
- Memantine hydrochlorideNMDA receptor antagonist
- Naratriptan5-HT1B/1D agonist (triptan)
- NatalizumabDisease-Modifying Therapy — MS (Anti-VLA-4 Monoclonal Antibody)
- NimodipineCalcium Channel Blocker (neuroprotective)
- NusinersenRare Neurological Disorders
- NusinersenAntisense oligonucleotide (SMN2 splicing modifier)
- OcrelizumabMultiple Sclerosis — Disease-Modifying Therapy
- OcrelizumabAnti-CD20 monoclonal antibody
- OfatumumabMultiple Sclerosis — Disease-Modifying Therapy
- OfatumumabAnti-CD20 monoclonal antibody
- OmaveloxoloneNrf2 activator
- OpicaponeCOMT inhibitor (3rd generation)
- Orphenadrine hydrochlorideAntimuscarinic (Parkinsonian)
- OxcarbazepineAntiepileptic — Sodium Channel Blocker
- OzanimodSphingosine-1-phosphate receptor modulator
- Peginterferon beta-1aPegylated interferon beta (immunomodulator)
- PerampanelAntiepileptic — AMPA Receptor Antagonist
- PhenytoinAntiepileptic (sodium channel blocker)
- PiracetamNootropic / GABA derivative
- PitolisantHistamine H3 receptor inverse agonist
- Pizotifen5-HT2 antagonist (antihistamine)
- PonesimodSphingosine-1-phosphate receptor 1 modulator
- PramipexoleDopamine Agonist (D2/D3 Receptor)
- PrimidoneBarbiturate-derived antiepileptic
- Procyclidine hydrochlorideAntimuscarinic
- Propranolol (Migraine Prevention)Beta-Blocker — Migraine Prophylaxis
- PyridostigmineAcetylcholinesterase Inhibitor — Myasthenia Gravis
- Pyridostigmine bromideReversible cholinesterase inhibitor
- RasagilineMAO-B Inhibitor — Parkinson's Disease
- RiluzoleNeuroprotective Agent — ALS/Motor Neurone Disease
- RimegepantCGRP receptor antagonist (gepant)
- Rivaroxaban (Stroke Prevention — AF)Direct Oral Anticoagulant — Factor Xa Inhibitor
- RivastigmineAcetylcholinesterase Inhibitor — Dementia
- RizatriptanSelective 5-HT1B/1D agonist (triptan)
- RopiniroleDopamine Agonist — Parkinson's Disease
- RotigotineDopamine Agonist — Transdermal Patch (Parkinson's / RLS)
- RozanolixizumabNeonatal Fc receptor (FcRn) antagonist
- RufinamideTriazole-derivative antiepileptic
- SafinamideSelective MAO-B inhibitor + glutamate modulation
- SatralizumabAnti-IL-6 receptor monoclonal antibody
- SelegilineMAO-B Inhibitor — Parkinson's Disease
- Selegiline hydrochlorideSelective MAO-B inhibitor
- SiponimodSphingosine-1-phosphate receptor 1/5 modulator
- Sodium oxybateGHB salt (CNS depressant)
- Sodium ValproateAntiepileptic / Mood stabiliser
- SolriamfetolDopamine-noradrenaline reuptake inhibitor
- StiripentolAntiepileptic (orphan)
- SumatriptanTriptan (5-HT1 agonist) / Antimigraine
- Sumatriptan with naproxenTriptan + NSAID combination
- Tenecteplase (Stroke)Stroke Thrombolysis
- TeriflunomidePyrimidine synthesis inhibitor
- TetrabenazineVMAT2 Inhibitor — Hyperkinetic Movement Disorders
- TiagabineGABA reuptake inhibitor (antiepileptic)
- TizanidineMuscle Relaxant — Alpha-2 Agonist
- TolcaponeCOMT inhibitor
- TopiramateAnticonvulsant (Multiple Mechanisms)
- TrihexyphenidylAnticholinergic — Parkinson's Disease / Dystonia
- Trihexyphenidyl hydrochlorideAntimuscarinic
- UblituximabAnti-CD20 monoclonal antibody
- Valproic acidAntiepileptic / mood stabiliser
- VamoroloneDissociative steroid
- VigabatrinAntiepileptic — GABA Transaminase Inhibitor
- ZilucoplanC5 complement inhibitor (subcutaneous)
- Zolmitriptan5-HT1B/1D Agonist (Triptan)
- ZonisamideAntiepileptic — Multiple Mechanisms